In low-income countries, data on prevalence and effects of group B Streptococcus (GBS) and Escherichia coli (E. coli) colonization among pregnant women are scarce, but necessary to formulate prevention strategies. We assessed prevalence of GBS and E. coli colonization and factors associated among pregnant women, its effect in newborns and acceptability regarding the utilized sampling methods in a semirural Mozambican hospital. Methods: Pregnant women were recruited from June 2014 to January 2015, during routine antenatal clinics at gestational age ≥ 34 weeks (n = 200); or upon delivery (n = 120). Maternal risk factors were collected. Vaginal and vagino-rectal samples for GBS and E. coli determination were obtained and characterized in terms of antimicrobial resistance and serotype. Anti-GBS antibodies were also determined. Neonatal follow-up was performed in the first 3 months after birth. Semistructured interviews were performed to investigate acceptability of sample collection methods. Results: In total, 21.3% of women recruited were GBS carriers, while 16.3% were positive for E. coli. Prevalence of HIV was 36.6%. No association was found between being colonized by GBS and E. coli and maternal risk factors. GBS isolates were fully susceptible to penicillin and ampicillin. Serotypes V (32.4%), Ia (14.7%) and III (10.3%) were the most commonly found and 69.2% of the women tested had immunoglobuline G antibodies against GBS. E. coli isolates showed resistance to ampicillin in 28.9% and trimethoprim/sulfamethoxazole in 61.3% of the cases. Conclusion: Prevalence of GBS and/or E. coli colonization among pregnant women is high in this semirural community and comparable with those reported in similar settings. Four serotypes accounted for nearly 70% of all isolates of GBS. Population-based data on infant GBS infections would enable the design of prevention strategies for GBS disease in Mozambique.
I
n 2016, 5.6 million children under 5 years of age died with nearly half of those deaths occurring in the neonatal period (< 28 days of age). 1 Neonatal deaths are disproportionately distributed across the globe, with 95% of them taking place in developing regions and infections remain a major contributor to this preventable mortality. 2, 3 Vertical transmission of bacteria that are normal commensal flora or pathogens of the maternal genitourinary and gastrointestinal tracts, such as group B Streptococcus (GBS) or Escherichia coli (E. coli) are leading determinants of neonatal morbidity and mortality, causing invasive bacterial infections that can manifest as sepsis, pneumonia and meningitis. 4, 5 GBS and E. coli are particularly associated with early-onset neonatal disease (EOD, 0-6 days after birth 6 ), but can also cause late-onset disease (7-89 days 7 ), preterm birth and very-low birth weight, 8, 9 all of which are responsible for substantial morbidity and mortality in sub-Saharan Africa (SSA). 2, 10, 11 The estimated incidence of GBS neonatal disease in sub-Saharan Africa (SSA) suggests a burden at least comparable with that found in high-income countries before the implementation of the preventive strategies. 12 Maternal GBS carriage at delivery determines the risk of vertical transmission, and thus of ensuing neonatal disease. Prevalence of maternal colonization varies from 6.5% to 36% 13 in Europe and has been reported higher than 20% in SubSaharan countries, although precise regional maternal carriage data for this continent are scarce. 12, 14, 15 Maternal risk factors associated with higher prevalence of GBS colonization are controversial. Both younger 16 and older maternal ages 17 have been reported as maternal characteristics associated with higher risk of GBS colonization, as well as higher education, 17 higher income 18 and high sexual activity. 17 The relation between HIV infection and risk for GBS maternal colonization has yet to be fully elucidated. Studies conducted in the United States 19 or in Zimbabwe 15 did not find an increased risk among HIV infected individuals, whereas researchers from South Africa 20 found a lower colonization prevalence among HIV-infected mothers. Vertical transmission of GBS may significantly increase (up to a 64% higher) among HIV-exposed infants compared with non-HIV exposed ones. 12 Currently, the primary intervention to reduce GBS-associated EOD involves the administration of intrapartum antibiotic prophylaxis (IAP) to women identified to either (1) be GBS carriers through microbiologic screening (35-37 weeks of gestation) 21 of samples obtained from their genito-urinary or gastrointestinal lower tract or (2) fulfill any of the different risk factors associated with neonatal disease. [22] [23] [24] In HIC, the widespread implementation of the IAP strategy has significantly reduced GBS EOD among those babies born to women in whom it was correctly applied. The IAP strategy has however not demonstrated any impact on GBSassociated late-onset disease, or in the prevention of E. coli neonatal disease of any kind. 12, 13 In low and lower middle income countries (LIC), the fragility of the health systems and the generalized lack of microbiology facilities, in the absence of a reliable rapid point of care test for GBS, hinders the applicability of the IAP strategy, therefore jeopardizing the prevention of life-threatening GBS neonatal infections. 12 Despite SSA having the highest incidence of neonatal sepsis worldwide, 12 epidemiologic data on GBS and E. coli maternal colonization in this continent are scarce. Additionally, and to our knowledge, no articles reporting E. coli colonization prevalence in pregnant women in Mozambique have been published and only 1 multicenter study conducted in South Africa, Kenya and Rwanda have determined simultaneously the vaginal GBS and E. coli carriage rates in SSA. 25, 26 Such data, however, appear necessary for a better and more evidence-based design of preventive strategies, based on the resources and infrastructures available.
This study aimed to determine the prevalence of pregnant women colonized by GBS and E. coli attending a semirural Mozambican hospital, analyze risk factors associated to higher risk of carriage by these pathogens and characterize the isolates in terms of antimicrobial resistance and serotype distribution. As secondary objectives, we determined the neonatal outcomes and assessed the feasibility and acceptability of collecting vaginal and vaginorectal samples among pregnant women, with the idea of generating locally relevant data useful to guide national preventive strategies and policies to reduce transmission and the toll of such potentially life-threatening infections in the newborn.
METHODS

Study Site
The study was conducted in Manhiça, a semirural site in Southern Mozambique. The Manhiça Health Research Center (CISM) runs a Demographic Surveillance System in the area and a morbidity surveillance system at the Manhiça District Hospital (MDH). 27 MDH is the referral hospital for the Manhiça district, covering a population of about 183,000 inhabitants. The MDH includes adult, pediatric and maternity wards, where between 3500 and 4000 deliveries take place annually. Institutional delivery rates are around 85-90% in the study area. MDH also includes an outpatient department and an antenatal care (ANC) clinic, where pregnant women are routinely followed. By national policy, all pregnant women are invited to attend antenatal consultations during their pregnancy. Manhiça district has one of the highest prevalence rates of HIV in the world, with HIV prevalence during pregnancy having been estimated at around 29% during antenatal consultations. 28 No strategy to prevent neonatal sepsis is currently implemented in Mozambique.
Study Design and Population
This observational prospective study was conducted at the ANC and delivery wards of MDH, between June 15, 2014, and January 15, 2015, running continuously during working hours (8:00-16:00) and working days. We recruited pregnant women at 2 different time-points during their pregnancy. One group during routine ANC with a minimum estimated gestational age ≥ 34 weeks, as measured by fundal height ≥ 32 cm, 2 cm above the midpoint between umbilicus and xiphoid process. A second group of women was recruited upon delivery (regardless of gestational age) if they were not recruited at ANC clinics, to understand real life risk for vertical transmission rate of GBS or E. coli to their offspring with no interference of antibiotic treatments. Participants were eligible for inclusion if they lived in the study area, were in good physical and mental health, able and willing to participate in the study and to provide informed consent. All women fulfilling inclusion criteria were eligible to participate in the study, and to obtain a more representative sample of the study population, the first 2 women seen every day were approached for recruitment.
Definitions
GBS colonization was considered in the event of a positive vaginal or vagino-rectal culture for GBS. E. coli colonization was considered when the positive vaginal culture grew E. coli. E. coli urinary tract infection was diagnosed when E. coli grew (> 10 5 colony-forming units/mL) in the urine samples of pregnant women. Abortion was defined as pregnancy termination before 20 weeks of gestation or a fetus born weighing less than 500 g. 29 A preterm baby was defined as that with a gestational age at birth < 37 weeks and stillbirth as intrauterine deaths occurring after 28 weeks of gestational age. Low birth weight was defined as weight at birth < 2500 g.
Study Procedures Sampling Procedures
Microbiologic swab samples were obtained from each participant (ANC or upon admission in labor at the delivery wards, but always before delivery) without the use of antiseptic solution or a speculum. A sample from the lower third of the vagina and a fresh urine sample were taken for E. coli determination. For GBS determination, samples included a lower vaginal swab (vaginal sample), and a single swab for the vagino-rectal sample, consisting on a sample of the vagina first and then the rectum obtained performing a brief rotation of the swab through the outer sphincter. Both kinds of swabs were collected in all women to compare the prevalence of GBS colonization detected by the 2 samples. Swabs were immediately placed in Amies transport medium and sent to the laboratory within 24 hours. The vaginal and vagino-rectal samples for GBS determination were inoculated directly onto Granada medium (Group B Streptococcus Differential Agar, Becton Dickinson, Erembodegem, Belgium) incubated anaerobically at 37ºC for 24 hours. Vaginal samples for E. coli determination were spread onto MacConkey agar, and urine samples were inoculated onto agar Cysteine lactose electrolyte deficient and MacConkey agar and incubated at 37ºC overnight without CO 2 . E. coli isolates were identified based on colony appearance, Gram stain, latex agglutination with the Pastorex Strepto kit (Bio-rad Laboratories®, Marnes-la-Coquette, France) and standard biochemical tests for E. coli determination. Both GBS and E. coli isolates were confirmed by MALDI-TOF. Resistance profiles were determined via KirbyBauer disk diffusion method after the Clinical & Laboratory Standards Institute guidelines.
Determination of the GBS capsular type or serotype implied the utilization of a multiplex-polymerasa chain reaction (PCR) using a set of primers described previously. 30 DNA of each isolate was obtained using the High Pure PCR Template Preparation kit (Roche, Spain). Briefly, this procedure consisted in performing 3 PCR reactions using specific primers for 10 different serotypes. Reaction 1 detects (Ia, Ib, II, III and IV), reaction 2 (V, VI, VII, VIII and IX) and reaction 3 is the amplification control. PCR conditions involved an initial step of 95ºC for 3 minutes, followed by 30 cycles of 95ºC for 1 minute, 57ºC for 1 minute and 72ºC for 2 minutes and a final step of 72ºC for 10 minutes. The PCR products were visualized by electrophoresis using 1% agarose gels. Antibody (AB) determination was identified in blood samples of mothers recruited at delivery. They were performed by Enzyme-linked immunosorbent assay (ELISA) using whole bacteria as antigens. This procedure is a modification based on the protocol proposed by Baker et al, 29 using an optical density to 450 nm with a correction at 620 nm. The cutoff value for positivity was chosen to be ≥ 1 OD units, to be more strict than the one proposed by Baker (> 0.125).
Maternal HIV infection status was determined and recorded if not previously known. Other screening tests routinely performed at ANC, such as syphilis or hemoglobin determination were also performed and recorded.
Communication of Results to Mothers and Case Management
For those women identified as carriers of GBS in vaginorectal swabs collected at the ANC, a field worker delivered to the mother at home a study card detailing the microbiologic findings, together with indications of what to do during delivery, so that intrapartum antibiotics could be administered to the mother, after the Centers for Disease Control and Prevention (CDC) guidelines. 31 Urinary tract infections secondary to E. coli were also reported and treated according to national guidelines for pregnant women. All recruited women were encouraged to deliver at hospital, and clinical staff was trained to identify them. Any child born to a recruited mother and found to be sick at delivery was assessed by a study clinician, and routine screening for bacterial surveillance (including a blood culture and a lumbar puncture to obtain cerebrospinal fluid) performed and clinical management organized according to MDH guidelines.
IAP was started in GBS-infected women upon labor initiation, according to CDC guidelines. 31 In cases where IAP could not be adequately performed, we followed Spanish recommendations and prophylactic antibiotic treatment (50,000 IU of intramuscular penicillin as a single dose for a newborn weighing > 2000 g, or 25,000 IU if weight < 2000 g) was administered within the first hour after birth to the newborns of mothers with confirmed GBS colonization. 32 Such children were observed at hospital for a minimum of 24 hours. For women recruited at delivery, culture results were not available until at least 24-48 hours after recruitment. In such cases (and also in cases of women with pending GBS result recruited before delivery), we kept the newborns under observation for a minimum of 24 hours after delivery and provided clear recommendations to mothers regarding the need for a follow-up visit should the newborn become sick in the first weeks of life. Babies born to study participant mothers were followed up during the first 3 months after birth.
Assessment of the Acceptability of Vaginal and Vagino-rectal Sampling
The study included a simple socio-behavioural component to evaluate the acceptability of collecting samples (vaginal and vagino-rectal swabs) during pregnancy. "Non-participant observations" were conducted, whereby a member of the study team observed the procedures being conducted (excluding genital examinations), and complemented by semistructured interviews to a small sample of pregnant women not participating in the study but contemporaneously attending the ANC. Finally, semistructured interviews were conducted among some participants who had accepted to provide vaginal and rectal samples. Questions, themes and probes arising from the nonparticipant observation, other than stated in the interview guide, were included in the semistructured interviews.
Statistical Analysis
All data were prospectively collected using standardized questionnaires, which were double entered in specific study databases, created using Openclinica © software. and were compared using the t test for normal distributions or the Mann-Whitney U test for skewed data. Logistic regression univariate and multivariate analyses were performed to identify risk factors for GBS or E. coli colonization, separately. Variables that were found to be significantly associated with GBS or E. coli in the univariate analysis together with those related at a significance level of P < 0.10 were entered into a multivariate model. Age and gestational age at recruitment were also included in the multivariate analysis based on previous studies. 9, [15] [16] [17] A separate univariate and multivariate analysis of risk factor associated to GBS or E. coli colonization among HIV pregnant women was also performed.
Ethical Considerations
This protocol and all supporting documentation (informed consent documents, study questionnaires) were approved by the local bioethics committee of CISM (Comité Institucional de Bioé-tica para Saúde do CISM), and by the National Bioethics Committee of Maputo in Mozambique; and by the Ethics Committee of the Hospital Clínic in Barcelona, Spain. Written information and consent forms in the local language were provided to the women. After the interview, participants were asked to express their willingness to participate in the study by signing (or thumb-printing in case they were illiterate) the consent form. Participation in this study was voluntary, and study-related procedures did not interfere with the pregnant women's or children's standard clinical care. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] , with no significant differences according to recruitment place. No major differences could be found in relation to recruitment site, with the exception of a higher frequency of higher education among women recruited upon delivery compared with those recruited at ANC (7.0% vs. 26.7%; P < 0.001). More than one-third of women (117/320, 36.6%) were HIV positive.
RESULTS
Between
Prevalence of GBS and E. coli Colonization Among Pregnant Women
More than a fifth (68/320; 21.3%) of all recruited women were colonized by GBS, detected in both samples in 33 women, in 15 in the vaginal one only and in 20 in the vagino-rectal one only. A nonstatistically significant higher proportion of GBS were isolated from the vagino-rectal sample (16.6%) as compared with the vagina (15.0%; P = 0.81). Prevalence of GBS colonization was borderline significantly higher among women recruited upon delivery compared with those recruited at ANC (32/120; 26.7% vs. 36/200 [18.0%]; P = 0.07). Fifty-two women had E. coli vaginal colonization (16.3%), being significantly more common among women recruited at delivery (22.5% vs. 12.5%; P = 0.019) and 10/320 (3.1%) had a positive E. coli urine culture. Among HIV-positive pregnant women recruited, GBS colonization was found in 26/117 (22.2%). E. coli vaginal colonization was determined in 18/117 (15.4%) HIV-positive women.
Anti-GBS Antibodies
Antibodies against GBS were detected in 83/120 (69.1%) women recruited at delivery. Of them, 23/32 (71.9%) were among GBS colonized mothers and 60/88 (68.2%) among noncolonized women (Fig. 1) . Among HIV-positive participants, AB anti-GBS were detected in 25/38 (65.8%) of those tested. Forty women had AB against more than one GBS serotype, being the most frequent AB against serotype Ia (24/120, 20%), against serotype Ib (76/120, 63.3%) and against serotype V (27/120, 22.5%). Correlating presence of antibodies to the homotypic GBS serotype, 2/4 (50%) women colonized by serotype Ia had AB against it, 6/6 (100%) for serotype Ib, 0/3 (0%) for serotype III and 7/14 (50%) of those carriers of Ib serotype had AB against their homotypic serotype. Table 1 presents the univariate analyses of associations of the different sociodemographics, clinical and laboratory variables with vaginal GBS and E. coli carriage. In the final multivariate GBS model (Table 2) , no risk factors were significantly associated with GBS carriage. Similarly, no risk factors appeared to be independently associated with maternal vaginal E. coli carriage ( Table 3) . The univariate and multivariate analyses performed to identify risk factors of GBS or E. coli colonization but restricted to HIV-infected women showed no differences compared with those including all women (data not shown).
Risk Factors Associated With GBS and E. coli Carriage
Antimicrobial Susceptibility and Serotyping
One hundred one specimens were found to be positive for GBS (48 vaginal and 53 vagino-rectal). All GBS isolates were fully sensitive to penicillin, ampicillin and ceftriaxone. Thirty-four (32.7%) isolates were resistant to erythromycin and 20 (19.2%) isolates to clindamycin. Seven isolates showed erythromycin-induced resistance to clindamycin. All the E. coli isolates were screened for susceptibility to 18 antimicrobial agents. Susceptibility to all antimicrobial agents tested was seen in 14 isolates (22.6%). E. coli was resistant to ampicillin in 21 (38.9%) cases, ceftriaxone in 2 (3.2%) cases, amoxicillin/clavulanate acid in 12 cases (19.4%), ciprofloxacin in 4 cases (6.5%) and co-trimoxazole in 38 cases (61.3%). The serotype distribution of the GBS isolates is presented in Figure 2 and Figure 3% and 8.8%, respectively) . Sixteen isolates (23.5%) were nontypeable. Twenty-six women had the same serotype detected both in the vaginal and vagino-rectal swabs, while in 7 cases infections were serotype-discordant.
Neonatal Outcomes
Three-hundred twenty neonatal outcomes from 316 pregnant women were recorded (98.8%). The delivery outcomes of 4 women in the ANC group were not registered at MDH. Neonatal outcomes included 4 pairs of twins, 290 term babies, 25 preterm and 5 cases of stillbirths. Table 1 . Thirty-two neonates born of 36 (88.9%) GBS carriers recruited at ANC were born at MDH and 4 outside of the health system. Due to lack of qualified clinical staff, work saturation and advanced stage of labor, IAP strategy as recommended by CDC 31 was feasible only in 2 known GBS carriers at the time of delivery; we administered a single dose of penicillin to 22 neonates in the first hour after birth. Two-hundred sixty-two infants (81.9%) were followed-up until 90 days of age, and 8/262 (3.1%) were admitted in the hospital during this period. Seven infants died among those followed up until 3 months after birth (2.7%), being 5 of them HIV-exposed (1 clinical sepsis, 1 perinatal asphyxia and 3 unknown causes). A significantly higher risk for death among those neonates born of mothers recruited at ANC compared with those recruited at delivery (3.6% vs. 1.7%; P < 0.001) was found.
Acceptability of Vaginal and Vagino-rectal Sampling
Fifteen study participant women and 5 nonstudy pregnant women were recruited for the social component. Acceptability of collecting vaginal and vagino-rectal samples was 100%. Facilitators for acceptance included: (1) willingness to know whether they had a reproductive tract infection; (2) being interested in understanding the objectives of collecting vaginal and vaginorectal samples and (3) willingness to be treated and accompanied to the hospital in case of reproductive tract infection and avoiding transmitting them to their offsprings. Only a few women felt uncomfortable with sample collection, referring to feeling of burning and/or pain. Although all participants of the social component accepted sample collection, possible barriers for acceptance of future vagino-rectal sample collection were explored and these included (1) fear in relation to the first time being submitted to this procedure; (2) worries regarding being seen at the hospital (stigma) and (3) lack of privacy at the ANC at time of sample collection. 
DISCUSSION
Maternal rate of GBS colonization found in this study, 21.3%, was as high as previous work in other countries in SSA reported. 12 However, 2 previous studies performed in the capital of Mozambique, Maputo, reported an extremely low prevalence of GBS colonization among pregnant women of 1% in 1995 33 and 1.8% in 2008. 34 Smaller sample sizes, different study population, and very likely laboratory and microbiology procedures utilized for GBS detection, may all contribute to explain the significant increase in terms of overall prevalence found in our study. Our findings are in close agreement with a systematic review on GBS disease in SSA, 12 which included 18 studies reporting data on maternal GBS colonization, finding an average GBS carriage of 21.8% (95% CI: 18.3-25.5) among pregnant women across the region. These results are also similar to general prevalence data from other regions, including the United States 9 and Europe, 13 or from other neighboring countries in SSA such as South Africa (with similar prevalence of HIV, 20, 35, 36 Zimbabwe 15 or Malawi, 37 supporting the credibility of these data. The yield of vagino-rectal sampling was better for GBS colonization than using only vaginal samples as previously reported 38, 39 and recommended. 31 No risk factors independently associated with higher prevalence of GBS colonization were found in this study. We adjusted the multivariate analysis by gestational age as previous studies examining the influence of advancing gestation on GBS colonization have observed that colonization rates appear to change overtime during pregnancy. 15, 40, 41 However, no associations between gestational age and colonization risk by GBS were found. Colonization prevalence was similar among age groups, in contrast to what has been described by some studies 16, 17, 42 but in concordance to a recent multicenter study performed in African settings, 35 reinforcing the idea that colonization rates are quite stable across a wide variety of African settings. We did not find higher education to be a risk factor for GBS colonization as other studies have reported, 18 a finding possibly influenced by the homogeneity of lower education backgrounds in our setting. Importantly, this study further contributes to expose the fact that current understanding on maternal risk factors for colonization is incomplete.
No increased risk of GBS colonization among HIV-infected women was found in this study, a finding supported by other studies in the United States and Zimbabwe. 15, 19 However, a South African study reported that maternal GBS carriage was lower in HIV-positive women and among those with lower CD4 counts in Malawi. 20, 37 This fact could be related to the fact that GBS carriage is inversely associated with the use of prophylactic co-trimoxazole among HIV-infected women. Information about co-trimoxazole use in this study was not recorded, but due to high prevalence of HIV in our cohort, it is likely that a high proportion of participants were routinely taking co-trimoxazole. Although HIV appears not to be a risk factor for maternal colonization during pregnancy, a recent South African study found that incidence of GBS neonatal disease may be up to 64% higher among HIV-exposed infants compared with non-HIV exposed ones. 12 As of today, no data are available regarding incidence of neonatal GBS invasive 28 found an incidence of GBS invasive disease among infants higher than that reported in other resource-constrained settings. 42, 44 Hence, it would appear reasonable to expect a high incidence of GBS invasive disease in this particularly HIV-struck study area. However, a low incidence of GBS invasive cases in neonates born to GBS infected women was found in this study. Reasons for this low incidence could be the high prevalence of antibodies against GBS found in the studied cohort (69.2%). Maternal antibody levels have been associated with protection against invasive GBS disease in high 45 and lower middle income settings, 46 and it has been documented that GBS placental transfer appears not to be affected by HIV infection. 47 It is difficult to correlate our GBS AB results with what is known regarding GBS maternal colonization and infant disease. The highest proportion of women with anti-GBS AB was against serotype Ib, Ia and V, consistent with predominant serotypes among carriers in our cohort. Although we did not examine antibody correlation between mothers and newborns, the higher prevalence of antibodies in our cohort could also potentially explain this low incidence of GBS invasive disease among our neonate cohort. In addition, prevalence of carriers of serotype III in this population, the known serotype causing more infant invasive disease, 48 was lower than reported in other African studies, 12 which would be also consistent with a lower incidence among infants. Another reason could be the attempt to implement IAP strategy to those colonized GBS mothers delivering at MDH. None of the neonates who received a single dose of penicillin after birth developed symptoms of sepsis. Understanding that this strategy is not generally recommended on account of the risks of enhancing antimicrobial resistance, and in spite of the small sample, it could be argued that for settings were access to health is problematic, but where GBS maternal carriage can be confirmed, such a strategy could prove effective in decreasing neonatal early morbidity by blocking the infection's transmissibility at a moment where the baby is still under the surveillance of the health system. The only GBS case in our study was a newborn developing symptoms in the first 24 hours, born to a mother recruited at delivery with negative GBS screening. This mother was HIV positive and was taking co-trimoxazole as prophylaxis of opportunistic infections, suggesting an intrauterine infection with a subsequent negativization.
On the other hand, the prevalence of E. coli found in this study was lower than that reported from other authors in different African settings 20, 35 but comparable with the prevalence reported by Karou et al 49 in Togo. No risk factors were found to be independently associated with a higher risk of E. coli vaginal carriage among pregnant women. Some studies have reported specific risk factors for E. coli colonization, including sexual practices such as anal intercourse during pregnancy 50 or being a sexual worker. 35 Such factors were however not explored in our study. Importantly, GBS continues to be susceptible to penicillin, ampicillin and ceftriaxone in our setting. Previous studies in Ethiopia 51, 52 and South Africa 18,49 also reported full susceptibility of GBS strains to penicillin. Rarer cases of decreased susceptibility to penicillin have been reported in Japan and the United States. 53 A study in Zimbabwe found almost 100% of isolates sensitive to penicillin, with 2% showing intermediate susceptibility to penicillin. Resistance to erythromycin resistance among invasive GBS isolates in Europe ranges from 3.8% to 21.2% 13 and from 7% to 25% in the United States and Canada. 24 Higher levels of resistance to erythromycin (~33%) were found in this study, which could be related to mass drug administration of azithromycin for trachoma control in SSA because development of macrolide-resistant pathogens after more than 1 round of mass treatment has already been reported. 54, 55 Erythromycin resistance is frequently associated with clindamycin resistance. 24 The emergence of nonsusceptible GBS strains has important public health implications. GBS is still susceptible to penicillin and ampicillin, which are the antibiotics of choice. Erythromycin and clindamycin are the drugs of choice for penicillin-hypersensitive patients, and resistance to these antibiotics is emerging.
As other studies have reported, 12 serotypes Ia, Ib, II, III and V were predominant. However, the most frequent serotype (V) found in this study differs from those found in the majority of studies conducted in other countries, revealing the need to identify prevalent serotypes in each region, as a prerequisite of establishing the potential coverage, impact and implementation requirements of future anti-GBS vaccination strategies.
Characterization of E. coli isolates from this study has been described by Sáez-López et al. 56 E. coli isolates showed significant resistance to co-trimoxazole, as a previous study on diarrhoeagenic E. coli 57 conducted in Manhiça already described. Reasons for such high co-trimoxazole resistance levels may include its extensive use as treatment of community-acquired infections, or as prophylaxis of HIV-related opportunistic infections. 58 This study has several limitations. Only women attending the MDH (and no other maternities) were included, and recruitment was not conducted after working hours, these being potential sources of selection bias and limiting the generalization of our results to the entire district. The first 2 women fulfilling inclusion criteria every day were invited to participate in the study, leading to only 200 women being recruited at ANC, and 120 additional ones upon delivery, an estimated 10% of all deliveries per year attended at MDH. Pregnant women are less likely to attend ANC at the end of their pregnancies, and some women who attend ANC in other maternities do actually choose MDH to deliver. Altogether this justifies our sampling strategy, but it is important to highlight that this convenience sample may not be truly representative of the entire pregnancy cohort in the area. We did not collect information about population not sampled, and we were unable to compare it with our population to assess such potential selection bias. However, the maternity at MDH is the biggest one in the study area, and women seen there come from different places of the district, and a sample of women attended at delivery was also recruited, minimizing bias. Other studies have reported association of other sexually transmitted infections such as gonorrhea or bacterial vaginosis 35 or socioeconomic status 42 with GBS colonization in pregnant women, but we did not measure these variables. However, an attempt was made to explore the majority of potential risk factors described by other authors. Finally, and albeit this not being an objective of the study, it was impossible to assess the risk of GBS and E. coli transmission in this cohort, due to the lack of denominator.
CONCLUSION
Screening mothers near term and providing appropriate antimicrobial prophylaxis could prevent potential adverse neonatal outcomes. Unfortunately, the fragility of the health system in LIC hinders the applicability of such approaches, and calls for innovative ideas to tackle these vertically transmitted infections. Serotype V was the most prevalent in our community, and 4 serotypes cause the majority of cases of GBS colonization. The development and implementation of a conjugate vaccine incorporating the most commonly found serotypes globally, could enhance the transfer of maternal antibodies to the baby and protect their health in those critical first moments for survival.
